This commentary refers to ‘Subgroup effects of ticagrelor monotherapy for acute coronary syndrome using individual patient data from the TICO and T-PASS trials’, by Y.J. Lee et al., https://doi.org/10.1093/eurheartj/ehae685, and the discussion piece ‘Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials’, by Y.J. Lee et al., https://doi.org/10.1093/eurheartj/ehae249.